Like_老虎社区_美港股上老虎

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":870547244,"tweetId":"870547244","gmtCreate":1636639277989,"gmtModify":1636639278261,"author":{"id":4089111593463300,"idStr":"4089111593463300","authorId":4089111593463300,"authorIdStr":"4089111593463300","name":"Vall","avatar":"https://static.tigerbbs.com/fe90033351c83d258018a489920a2d49","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":19,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Like</p></body></html>","htmlText":"<html><head></head><body><p>Like</p></body></html>","text":"Like","highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/870547244","repostId":1156346284,"repostType":4,"repost":{"id":"1156346284","pubTimestamp":1636636405,"share":"https://www.laohu8.com/m/news/1156346284?lang=&edition=full","pubTime":"2021-11-11 21:13","market":"us","language":"en","title":"ADMA Biologics Shares Rise On Lower Than Expected Q3 Loss, Sales Double","url":"https://stock-news.laohu8.com/highlight/detail?id=1156346284","media":"Benzinga","summary":"ADMA Biologics Inc achieved Q3 sales of $20.7 million, + 101% Y/Y, beating the consensus of $18.72 m","content":"<ul>\n <li><b>ADMA Biologics Inc</b>&nbsp;achieved Q3 sales of $20.7 million, + 101% Y/Y, beating the consensus of $18.72 million.</li>\n <li>The increase was favorably impacted by the continued commercial ramp-up of ADMA's intravenous immune globulin (IVIG) product portfolio and the sale of intermediate fractions.</li>\n <li>The company generated a gross profit of $0.4 million compared to a gross loss of $(1.6) million a year ago, primarily attributable to increased sales of ADMA's higher-margin hyperimmune globulin product portfolio, along with a portion of the sales generated from conformance batches.</li>\n <li>Q3 consolidated net loss reached $(17.7) million, compared to $(16.9) million last year. EPS loss was $(0.13) compared to $(0.19) a year ago, better than the consensus of $(0.14).</li>\n <li>ADMA had cash and equivalents of $34.4 million and accounts receivable of $20.4 million as of September 30, 2021. On October 25, 2021, the company raised $53.9 million through a public offering.</li>\n <li><b>Price Action:</b>&nbsp;ADMA shares are up 10.7% at $1.55 during the premarket session on the last check Thursday.</li>\n</ul>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ADMA Biologics Shares Rise On Lower Than Expected Q3 Loss, Sales Double</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nADMA Biologics Shares Rise On Lower Than Expected Q3 Loss, Sales Double\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-11 21:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/general/biotech/21/11/24036746/adma-biologics-shares-rise-on-lower-than-expected-q3-loss-sales-double><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>ADMA Biologics Inc achieved Q3 sales of $20.7 million, + 101% Y/Y, beating the consensus of $18.72 million.\nThe increase was favorably impacted by the continued commercial ramp-up of ADMA's ...</p>\n\n<a href=\"https://www.benzinga.com/general/biotech/21/11/24036746/adma-biologics-shares-rise-on-lower-than-expected-q3-loss-sales-double\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ADMA":"ADMA Biologics Inc"},"source_url":"https://www.benzinga.com/general/biotech/21/11/24036746/adma-biologics-shares-rise-on-lower-than-expected-q3-loss-sales-double","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1156346284","content_text":"ADMA Biologics Inc achieved Q3 sales of $20.7 million, + 101% Y/Y, beating the consensus of $18.72 million.\nThe increase was favorably impacted by the continued commercial ramp-up of ADMA's intravenous immune globulin (IVIG) product portfolio and the sale of intermediate fractions.\nThe company generated a gross profit of $0.4 million compared to a gross loss of $(1.6) million a year ago, primarily attributable to increased sales of ADMA's higher-margin hyperimmune globulin product portfolio, along with a portion of the sales generated from conformance batches.\nQ3 consolidated net loss reached $(17.7) million, compared to $(16.9) million last year. EPS loss was $(0.13) compared to $(0.19) a year ago, better than the consensus of $(0.14).\nADMA had cash and equivalents of $34.4 million and accounts receivable of $20.4 million as of September 30, 2021. On October 25, 2021, the company raised $53.9 million through a public offering.\nPrice Action: ADMA shares are up 10.7% at $1.55 during the premarket session on the last check Thursday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":461,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":4,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/870547244"}